4.5 Article

Nailfold Videocapillaroscopic Features and Other Clinical Risk Factors for Digital Ulcers in Systemic Sclerosis: A Multicenter, Prospective Cohort Study

Journal

ARTHRITIS & RHEUMATOLOGY
Volume 68, Issue 10, Pages 2527-2539

Publisher

WILEY
DOI: 10.1002/art.39718

Keywords

-

Categories

Funding

  1. Actelion Pharmaceuticals
  2. FWO [1.5.217.13N]
  3. FWO Senior Clinical Investigator fellowship
  4. University of Genoa from Actelion Pharmaceuticals
  5. Bristol-Myers Squibb
  6. Horizon
  7. Apricus
  8. 4D Science
  9. Active Biotec
  10. EpiPharm
  11. Biogen Idec
  12. Genentech/Roche
  13. GlaxoSmithKline
  14. Inventiva
  15. Lilly
  16. Pfizer
  17. Serodapharm
  18. Sinoxa
  19. ErgoNex
  20. Pharmacyclics
  21. Sanofi
  22. Bayer
  23. Boehringer Ingelheim
  24. Medac
  25. Galapagos

Ask authors/readers for more resources

ObjectiveTo identify nailfold videocapillaroscopic features and other clinical risk factors for new digital ulcers (DUs) during a 6-month period in patients with systemic sclerosis (SSc). MethodsIn this multicenter, prospective, observational cohort study, the videoCAPillaroscopy (CAP) study, we evaluated 623 patients with SSc from 59 centers (14 countries). Patients were stratified into 2 groups: a DU history group and a no DU history group. At enrollment, patients underwent detailed nailfold videocapillaroscopic evaluation and assessment of demographic characteristics, DU status, and clinical and SSc characteristics. Risk factors for developing new DUs were assessed using univariable and multivariable logistic regression (MLR) analyses. ResultsOf the 468 patients in the DU history group (meanSD age 54.0 +/- 13.7 years), 79.5% were female, 59.8% had limited cutaneous SSc, and 22% developed a new DU during follow-up. The strongest risk factors for new DUs identified by MLR in the DU history group included the mean number of capillaries per millimeter in the middle finger of the dominant hand, the number of DUs (categorized as 0, 1, 2, or 3), and the presence of critical digital ischemia. The receiver operating characteristic (ROC) of the area under the curve (AUC) of the final MLR model was 0.738 (95% confidence interval [95% CI] 0.681-0.795). Internal validation through bootstrap generated a ROC AUC of 0.633 (95% CI 0.510-0.756). ConclusionThis international prospective study, which included detailed nailfold videocapillaroscopic evaluation and extensive clinical characterization of patients with SSc, identified the mean number of capillaries per millimeter in the middle finger of the dominant hand, the number of DUs at enrollment, and the presence of critical digital ischemia at enrollment as risk factors for the development of new DUs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available